| | 英文名称 | | 中文名称 | | CAS |
|---|---|---|
| belimumab | 贝利木单抗 | 356547-88-1 |
| Aselizumab | 阿塞珠单抗 | 395639-53-9 |
| Altumomab | 阿妥莫单抗 | 156586-92-4 |
| 4-(N,N-Diethyl)-2-methyl-p-phenylenediamine monohydrochloride | 4-(N,N-二乙基)-2-甲基苯二胺盐酸盐 | 2051-79-8 |
| abciximab | ABCIXIMAB | 143653-53-6 |
| Bertilimumab | 柏替木单抗 | 375348-49-5 |
| RAT IL-10 | 白细胞介素10 | 350590-73-7 |
| Bevacizumab | 贝伐珠单抗 | 216974-75-3 |
| Anti-BR140-like protein antibody produced in rabbit | Anti-BR140-like protein antibody produced in rabbit | 1597439-92-3 |
| Atezolizumab | 阿特珠单抗 | 1380723-44-3 |
| guselkumab | 古塞库单抗 | 1350289-85-8 |
| Lintuzumab | Lintuzumab | 166089-32-3 |
| Infliximab | 英夫利昔单抗 | 170277-31-3 |
| Faralimomab | Faralimomab | 167816-91-3 |
| Nivolumab | 纳武单抗 | 946414-94-4 |
| Urelumab | 乌瑞芦单抗 | 934823-49-1 |
| Foravirumab | 夫瑞韦如 | 944548-38-3 |
| rafivirumab | 瑞非韦鲁 | 944548-37-2 |
| Canakinumab | 卡那津单抗 | 914613-48-2 |
| Romosozumab | ROMOSOZUMAB | 909395-70-6 |
